Last month, Revolution Medicines’ RAS inhibitor doubled survival in a Phase 3 pancreatic cancer trial. On the biotech’s heels are Immuneering, Actuate Therapeutics, Erasca and more, looking to improve ...

A new stem-cell-derived model suggests human pancreatic cells require multiple genetic failures before becoming cancerous and ...

New research on more than 100 cancer risk factors suggests that simple life changes can help prevent cancer or spot it early ...

Can the heart develop cancer? A cardiologist explains why it is considered one of the most cancer-resistant organs in the ...

An artificial intelligence model from the Mayo Clinic detected early signs of possible pancreatic cancer on scans up to two years before patients were diagnosed.

Exelixis, Inc. (Nasdaq: EXEL) today announced that the company has entered into a clinical development collaboration with Merck, known as MSD outside of the United States and Canada, to supply ...

The Director of the University of Chicago Medicine Comprehensive Cancer Centre and Fellow of the Nigerian Academy of Science, Prof Kunle Odunsi, has said one in four people will develop cancer in ...

Researchers have discovered that different dietary fats may have dramatically different effects on pancreatic cancer, with ...